Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

361 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effect of methylation on the let-7-BCL2L1-BCL2 axis and the potential use of hypomethylating and BH3 mimetic drugs in histiocytic neoplasms.
Salmon-Divon M, Meyuchas R, Shpilberg O, Okon E, Benhamida J, Yabe M, Petrova-Drus K, Zvida-Bloch T, Basood M, Mazor R, Durham BH, Haroche J, Abdel-Wahab O, Diamond EL, Hershkovitz-Rokah O. Salmon-Divon M, et al. Among authors: abdel wahab o. Leukemia. 2024 Nov 8. doi: 10.1038/s41375-024-02459-5. Online ahead of print. Leukemia. 2024. PMID: 39516372 No abstract available.
Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy.
Friedman JS, Durham BH, Reiner AS, Yabe M, Petrova-Drus K, Dogan A, Pulitzer M, Busam KJ, Francis JH, Rampal RK, Ulaner GA, Reddy R, Yeh R, Hatzoglou V, Lacouture ME, Rotemberg V, Mazor RD, Hershkovitz-Rokah O, Shpilberg O, Goyal G, Go RS, Abeykoon JP, Rech K, Morlote D, Fidai S, Gannamani V, Zia M, Abdel-Wahab O, Panageas KS, Rosenblum MK, Diamond EL. Friedman JS, et al. Br J Haematol. 2024 Jul;205(1):127-137. doi: 10.1111/bjh.19462. Epub 2024 Apr 12. Br J Haematol. 2024. PMID: 38613141
Histiocytic neoplasm subtypes differ in their MAP2K1 mutational type.
Emile JF, Hélias-Rodzewicz Z, Durham BH, Héritier S, da Silva M, Younas K, Cohen-Aubart F, Abdel-Wahab O, Diamond EL, Donadieu J, Haroche J. Emile JF, et al. Blood Adv. 2023 Dec 12;7(23):7254-7257. doi: 10.1182/bloodadvances.2023011414. Blood Adv. 2023. PMID: 37878806 Free PMC article.
Vemurafenib and Obinutuzumab as Frontline Therapy for Hairy Cell Leukemia.
Park JH, Devlin S, Durham BH, Winer ES, Huntington S, von Keudell G, Vemuri S, Shukla M, Falco V, Cuello B, Gore S, Stone R, Abdel-Wahab O, Tallman MS. Park JH, et al. NEJM Evid. 2023 Oct;2(10):EVIDoa2300074. doi: 10.1056/EVIDoa2300074. Epub 2023 Sep 21. NEJM Evid. 2023. PMID: 38320179 Free PMC article.
Targeting the cBAF complex in T-ALL.
Chen B, Abdel-Wahab O. Chen B, et al. Blood. 2024 Feb 15;143(7):566-567. doi: 10.1182/blood.2023023040. Blood. 2024. PMID: 38358848 No abstract available.
A new SAGA for AML: targeting SGF29 in AML.
Biswas J, Abdel-Wahab O. Biswas J, et al. Blood. 2024 Feb 22;143(8):657-658. doi: 10.1182/blood.2023023442. Blood. 2024. PMID: 38386429 No abstract available.
361 results